Pharmacoepidemiology and Drug Safety This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 245-252, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 11, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 245-252, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 11, 2018 Category: Drugs & Pharmacology Source Type: research
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 263-271, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 10, 2018 Category: Drugs & Pharmacology Source Type: research
Relevance of frailty to mortality associated with the use of antipsychotics among community ‐residing older adults with impaired cognition
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 289-298, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 10, 2018 Category: Drugs & Pharmacology Source Type: research
Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta ‐analysis of observational studies
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 279-288, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 10, 2018 Category: Drugs & Pharmacology Source Type: research
Risk factors for medication errors at admission in preoperatively screened patients
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 272-278, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 10, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 263-271, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 10, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 289-298, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 10, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 279-288, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 10, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 272-278, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 10, 2018 Category: Drugs & Pharmacology Source Type: research
Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta ‐analysis of observational studies
ConclusionsCurrent evidence indicates that use of diuretics might be associated with increased risk of KC, while ACE inhibitors or ARBs might be associated with decreased risk in high‐risk individuals. β‐blockers or CCBs might be positively associated with BCC risk. Further postmarketing surveillance studies and investigations to clarify the possible underlying mechanisms are warranted. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 10, 2018 Category: Drugs & Pharmacology Authors: Huilin Tang, Shuangshuang Fu, Suodi Zhai, Yiqing Song, Maryam M. Asgari, Jiali Han Tags: ORIGINAL REPORT Source Type: research
Risk factors for medication errors at admission in preoperatively screened patients
ConclusionIn one‐third of preoperatively screened patients, an MEA was found. The number of medications and respiratory comorbidities are risk factors for MEA in preoperatively screened patients. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 10, 2018 Category: Drugs & Pharmacology Authors: Marieke M. Ebbens, Kim B. Gombert ‐Handoko, Muhammad Al‐Dulaimy, Patricia M.L.A. Bemt, Elsbeth J. Wesselink Tags: ORIGINAL REPORT Source Type: research
Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 340-348, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 9, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 340-348, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 9, 2018 Category: Drugs & Pharmacology Source Type: research
Validation of an algorithm for identifying type 1 diabetes in adults based on electronic health record data
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 2, 2018 Category: Drugs & Pharmacology Source Type: research